JP2002511090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002511090A5 JP2002511090A5 JP1999505516A JP50551699A JP2002511090A5 JP 2002511090 A5 JP2002511090 A5 JP 2002511090A5 JP 1999505516 A JP1999505516 A JP 1999505516A JP 50551699 A JP50551699 A JP 50551699A JP 2002511090 A5 JP2002511090 A5 JP 2002511090A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/885,397 | 1997-06-30 | ||
| US08/885,768 US6624173B1 (en) | 1997-06-30 | 1997-06-30 | Pharmaceutical compositions for treating and/or preventing CNS disorders |
| US08/885,397 US6525065B1 (en) | 1997-06-30 | 1997-06-30 | Pharmaceutical compositions and methods for effecting dopamine release |
| US08/885,768 | 1997-06-30 | ||
| PCT/US1998/008145 WO1999000385A1 (en) | 1997-06-30 | 1998-04-22 | 3-pyridyl-1-aza-bicyclo-alkane derivatives for prevention and treatment of cns disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002511090A JP2002511090A (ja) | 2002-04-09 |
| JP2002511090A5 true JP2002511090A5 (https=) | 2005-12-22 |
Family
ID=27128761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50551699A Ceased JP2002511090A (ja) | 1997-06-30 | 1998-04-22 | Ｃｎｓ疾患の予防と治療用３−ピリジル−１−アザ−ビシクロ−アルカン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0994875B1 (https=) |
| JP (1) | JP2002511090A (https=) |
| AT (1) | ATE261443T1 (https=) |
| AU (1) | AU7149798A (https=) |
| CA (1) | CA2294990C (https=) |
| DE (1) | DE69822300T2 (https=) |
| DK (1) | DK0994875T3 (https=) |
| ES (1) | ES2214707T3 (https=) |
| PT (1) | PT994875E (https=) |
| WO (1) | WO1999000385A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6432975B1 (en) | 1998-12-11 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| US6953855B2 (en) | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| FR2791678B1 (fr) * | 1999-03-30 | 2001-05-04 | Synthelabo | Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique |
| EP1225955A1 (en) * | 1999-11-01 | 2002-07-31 | Targacept, Inc. | Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| US6890935B2 (en) | 1999-11-01 | 2005-05-10 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| EP1315493A4 (en) * | 2000-08-21 | 2007-12-05 | Univ Georgetown | 2-3-DISUBSTITUTED QUINUCLIDINS AS MONOAMINE CARRIER MODULATORS AND THERAPEUTIC AND DIAGNOSTIC METHODS BASED THEREON |
| HK1054393B (en) | 2000-09-20 | 2009-08-28 | Ortho-Mcneil Pharmaceutical, Inc. | Pyrazine derivatives as modulators of tyrosine kinases |
| GB0202873D0 (en) * | 2002-02-07 | 2002-03-27 | Novartis Ag | Organic compounds |
| JP4923630B2 (ja) * | 2006-03-02 | 2012-04-25 | 宇部興産株式会社 | ４−置換テトラヒドロピランの製造方法 |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| JP5413441B2 (ja) * | 2011-12-09 | 2014-02-12 | 宇部興産株式会社 | ４−置換テトラヒドロピランの製造方法 |
| CN104311514B (zh) * | 2014-10-14 | 2016-06-22 | 安徽扬子化工有限公司 | 3-羟甲基四氢呋喃酯的合成方法 |
| CN117624393A (zh) * | 2023-11-24 | 2024-03-01 | 中国科学院烟台海岸带研究所 | 一种吡啶基席夫碱阴离子化菊糖季铵盐及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0412798A3 (en) * | 1989-08-08 | 1992-07-01 | Merck Sharp & Dohme Ltd. | Substituted pyridines, their preparation, formulations and use in dementia |
| US5242935A (en) * | 1992-03-06 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| AU7474794A (en) * | 1993-07-22 | 1995-02-20 | E.I. Du Pont De Nemours And Company | Arthropodicidal azacyclic heterocycles |
| US5510355A (en) * | 1994-09-06 | 1996-04-23 | Bencherif; Merouane | Depolarizing skeletal muscle relaxants |
| WO1996036637A1 (en) * | 1995-05-17 | 1996-11-21 | R.J. Reynolds Tobacco Company | Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
-
1998
- 1998-04-22 EP EP98918598A patent/EP0994875B1/en not_active Expired - Lifetime
- 1998-04-22 ES ES98918598T patent/ES2214707T3/es not_active Expired - Lifetime
- 1998-04-22 DK DK98918598T patent/DK0994875T3/da active
- 1998-04-22 JP JP50551699A patent/JP2002511090A/ja not_active Ceased
- 1998-04-22 DE DE69822300T patent/DE69822300T2/de not_active Expired - Fee Related
- 1998-04-22 PT PT98918598T patent/PT994875E/pt unknown
- 1998-04-22 CA CA002294990A patent/CA2294990C/en not_active Expired - Fee Related
- 1998-04-22 AT AT98918598T patent/ATE261443T1/de not_active IP Right Cessation
- 1998-04-22 AU AU71497/98A patent/AU7149798A/en not_active Abandoned
- 1998-04-22 WO PCT/US1998/008145 patent/WO1999000385A1/en not_active Ceased